-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Highlights from Veterinary Meeting & Expo 2023
- Share
- Tweet
- Share on Facebook
- Share
A short video highlighting Volition Veterinary’s attendance at VMX 2023. Watch for an update on the availability of Nu.Q® Vet through IDEXX’s reference laboratory network, a snippet from a Key Opinion Leader panel, Heska’s exclusive point of care license and supply agreement with Volition, and more.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields